Bharat M. Chowrira

Filings by Bharat M. Chowrira span 3 companies, the busiest being Sirna Therapeutics Inc, Auspex Pharmaceuticals, Inc. and Karuna Therapeutics, Inc. We count 8 filings; the first trade dates from 21 February 2006 and the latest from 2 July 2019.

On the market, this insider has only ever bought: 3 purchases, €262k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 share grants. Since January 2019: 2 purchases and no sales on the market.

A typical purchase (the median) is worth €91k.

The latest filing, published on 2 July 2019, reports an open-market purchase of €97k in Karuna Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.